Chris Tucker is a seasoned Principal Scientist at Astellas Pharma, bringing nearly two decades of extensive experience in the pharmaceutical industry, particularly in analytical chemistry and drug metabolism and pharmacokinetics (DMPK). His expertise spans a diverse range of modalities, including oligonucleotides, recombinant proteins, and small...
Chris Tucker is a seasoned Principal Scientist at Astellas Pharma, bringing nearly two decades of extensive experience in the pharmaceutical industry, particularly in analytical chemistry and drug metabolism and pharmacokinetics (DMPK). His expertise spans a diverse range of modalities, including oligonucleotides, recombinant proteins, and small molecules, making him a versatile asset in the development of innovative therapeutics.
At Astellas, Chris plays a pivotal role in the bioanalysis of small molecule pharmaceutical compounds, utilizing his specialized skills in LC/MS/MS to ensure the accuracy and reliability of analytical results. His proficiency in building Good Laboratory Practice (GLP) bioanalytical infrastructure from the ground up has been instrumental in establishing robust processes that comply with regulatory standards. This foundational work not only enhances the efficiency of bioanalytical assay development but also supports the overall drug development pipeline.
Chris's commitment to excellence in assay development is complemented by his deep understanding of protein purification and Good Manufacturing Practice (GMP) standards. His ability to integrate analytical chemistry with practical applications in drug metabolism has positioned him as a thought leader within the industry. As he continues to contribute to key projects at Astellas, Chris remains dedicated to advancing the field of pharmaceutical sciences, leveraging his extensive background to drive innovation and improve patient outcomes. His work exemplifies the critical intersection of science and strategy in the ever-evolving landscape of drug development.
